EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Availability and affordability of anti-VEGF biosimilars for the treatment of age-related macular degeneration and diabetic macular oedema in Sri Lanka

Mapa Prabhath Piyasena, Mangala Dhanapala

Community Eye Health Journal · 29.01.2025 · 37 (125)

DOI: 10.56920/cehj.836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Community Eye Health Journal, online erschienen am 29.01.2025. Verfasst von Mapa Prabhath Piyasena und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Piyasena, M. P., & Dhanapala, M. (2025). Availability and affordability of anti-VEGF biosimilars for the treatment of age-related macular degeneration and diabetic macular oedema in Sri Lanka. Community Eye Health Journal, 37(125). https://doi.org/10.56920/cehj.836

Vancouver

Piyasena MP, Dhanapala M. Availability and affordability of anti-VEGF biosimilars for the treatment of age-related macular degeneration and diabetic macular oedema in Sri Lanka. Community Eye Health Journal. 2025;37(125). doi:10.56920/cehj.836

BibTeX
@article{Piyasena2025,
  author = {Piyasena, Mapa Prabhath and Dhanapala, Mangala},
  title = {Availability and affordability of anti-VEGF biosimilars for the treatment of age-related macular degeneration and diabetic macular oedema in Sri Lanka},
  journal = {Community Eye Health Journal},
  year = {2025},
  volume = {37},
  number = {125},
  doi = {10.56920/cehj.836}
}
Kostenlos starten →